Marina Biotech, Inc. (MRNA) Starts Presentation at 4th Annual LD Micro Conference

Marina Biotech, Inc. (OTC: MRNA) is an oligonucleotide therapeutics company with broad drug discovery technologies providing the ability to develop proprietary single and double-stranded nucleic acid therapeutics including siRNAs, microRNA mimics, antagomirs, and antisense compounds, including messenger RNA therapeutics. The company believes that its technologies have unique strengths as a drug discovery engine for the development of nucleic acid-based therapeutics for rare and orphan diseases. For more information, visit the company’s website at www.marinabio.com